The role of treatment timing and mode of stimulation in the treatment of primary dysmenorrhea with acupuncture: An exploratory randomised controlled trial - PubMed
- ️Sun Jan 01 2017
Randomized Controlled Trial
. 2017 Jul 12;12(7):e0180177.
doi: 10.1371/journal.pone.0180177. eCollection 2017.
Affiliations
- PMID: 28700680
- PMCID: PMC5507497
- DOI: 10.1371/journal.pone.0180177
Randomized Controlled Trial
The role of treatment timing and mode of stimulation in the treatment of primary dysmenorrhea with acupuncture: An exploratory randomised controlled trial
Mike Armour et al. PLoS One. 2017.
Abstract
Objectives: We examined the effect of changing treatment timing and the use of manual, electro acupuncture on the symptoms of primary dysmenorrhea.
Methods: A randomised controlled trial was performed with four arms, low frequency manual acupuncture (LF-MA), high frequency manual acupuncture (HF-MA), low frequency electro acupuncture (LF-EA) and high frequency electro acupuncture (HF-EA). A manualised trial protocol was used to allow differentiation and individualized treatment over three months. A total of 74 women were randomly assigned to one of the four groups (LF-MA n = 19, HF-MA n = 18, LF-EA n = 18, HF-EA n = 19). Twelve treatments were performed over three menstrual cycles, either once per week (LF groups) or three times in the week prior to menses (HF groups). All groups received a treatment in the first 48 hours of menses. The primary outcome was the reduction in peak menstrual pain at 12 months from trial entry.
Results: During the treatment period and nine month follow-up all groups showed statistically significant (p < .001) reductions in peak and average menstrual pain compared to baseline but there were no differences between groups (p > 0.05). Health related quality of life increased significantly in six domains in groups having high frequency of treatment compared to two domains in low frequency groups. Manual acupuncture groups required less analgesic medication than electro-acupuncture groups (p = 0.02). HF-MA was most effective in reducing secondary menstrual symptoms compared to both-EA groups (p<0.05).
Conclusion: Acupuncture treatment reduced menstrual pain intensity and duration after three months of treatment and this was sustained for up to one year after trial entry. The effect of changing mode of stimulation or frequency of treatment on menstrual pain was not significant. This may be due to a lack of power. The role of acupuncture stimulation on menstrual pain needs to be investigated in appropriately powered randomised controlled trials.
Conflict of interest statement
Competing Interests: MA is the director of an acupuncture clinic in New Zealand and has recently been engaged in integrative medicine clinical practice. MA, CS and XZ are part of NICM. As a medical research institute, NICM receives research grants and donations from foundations, universities, government agencies, individuals and industry. Sponsors and donors provide untied funding for work to advance the vision and mission of the Institute. The project that is the subject of this article was not undertaken as part of a contractual relationship with any organisation other than the funding declared in the Acknowledgments. It should also be noted that NICM conducts clinical trials relevant to this topic area, for which further details can be provided on request. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures
Similar articles
-
Armour M, Smith CA. Armour M, et al. Acupunct Med. 2016 Dec;34(6):416-424. doi: 10.1136/acupmed-2016-011110. Epub 2016 Nov 14. Acupunct Med. 2016. PMID: 27913451 Review.
-
A randomized controlled trial of single point acupuncture in primary dysmenorrhea.
Liu CZ, Xie JP, Wang LP, Liu YQ, Song JS, Chen YY, Shi GX, Zhou W, Gao SZ, Li SL, Xing JM, Ma LX, Wang YX, Zhu J, Liu JP. Liu CZ, et al. Pain Med. 2014 Jun;15(6):910-20. doi: 10.1111/pme.12392. Epub 2014 Mar 17. Pain Med. 2014. PMID: 24636695 Clinical Trial.
-
Chien TJ, Huang YS, Liao LL, Chu CC, Pai JH. Chien TJ, et al. J Integr Complement Med. 2024 Jun;30(6):560-575. doi: 10.1089/jicm.2023.0183. Epub 2024 Feb 16. J Integr Complement Med. 2024. PMID: 38364185 Clinical Trial.
-
Woo HL, Ji HR, Pak YK, Lee H, Heo SJ, Lee JM, Park KS. Woo HL, et al. Medicine (Baltimore). 2018 Jun;97(23):e11007. doi: 10.1097/MD.0000000000011007. Medicine (Baltimore). 2018. PMID: 29879061 Free PMC article. Review.
-
Vixner L, Mårtensson LB, Schytt E. Vixner L, et al. BMC Complement Altern Med. 2015 Jun 12;15:180. doi: 10.1186/s12906-015-0708-2. BMC Complement Altern Med. 2015. PMID: 26066641 Free PMC article. Clinical Trial.
Cited by
-
Tsonis O, Gkrozou F, Barmpalia Z, Makopoulou A, Siafaka V. Tsonis O, et al. Int J Womens Health. 2021 Mar 17;13:327-336. doi: 10.2147/IJWH.S264023. eCollection 2021. Int J Womens Health. 2021. PMID: 33762855 Free PMC article. Review.
-
Han S, Park KS, Lee H, Kim E, Zhu X, Lee JM, Suh HS. Han S, et al. Cochrane Database Syst Rev. 2024 Jul 22;7(7):CD013331. doi: 10.1002/14651858.CD013331.pub2. Cochrane Database Syst Rev. 2024. PMID: 39037764
-
Zhai SJ, Ruan Y, Liu Y, Lin Z, Xia C, Fang FF, Zhou QH. Zhai SJ, et al. Medicine (Baltimore). 2020 Mar;99(12):e19496. doi: 10.1097/MD.0000000000019496. Medicine (Baltimore). 2020. PMID: 32195949 Free PMC article. Clinical Trial.
-
Xu X, Zhang M, Wu X, Zheng C, Huang G. Xu X, et al. Evid Based Complement Alternat Med. 2022 Jan 4;2022:2564979. doi: 10.1155/2022/2564979. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35027932 Free PMC article.
-
Arentz S, Smith C, Redmond R, Abbott J, Armour M. Arentz S, et al. BMC Complement Med Ther. 2021 Jun 24;21(1):174. doi: 10.1186/s12906-021-03355-6. BMC Complement Med Ther. 2021. PMID: 34167548 Free PMC article.
References
-
- Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332(7550):1134–8. doi: 10.1136/bmj.332.7550.1134 - DOI - PMC - PubMed
-
- Wong CL, Farquhar C, Roberts H, Proctor M. Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev. 2009(4):CD002120 doi: 10.1002/14651858.CD002120.pub3 - DOI - PMC - PubMed
-
- Latthe P, Latthe M, Say L, Gülmezoglu M, Khan KS. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006;6:177 doi: 10.1186/1471-2458-6-177 - DOI - PMC - PubMed
-
- Pitts MK, Ferris JA, Smith AM, Shelley JM, Richters J. Prevalence and correlates of three types of pelvic pain in a nationally representative sample of Australian women. Med J Aust. 2008;189(3):138–43. - PubMed
-
- Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol. 2001;14(1):3–8. - PubMed
Publication types
MeSH terms
Grants and funding
This study was funded in part by the Australian federal government via their Australian postgraduate award to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous